Table 1.

Characteristics of the three study populations (2010–2016).

	U.S. (/1000 people)	Ontario (/1000 people)	Australia (/1000 people)
Study population, n	3888	2595	1787
Age, n (%)
65–74	2442 (62.8)	1736 (66.9)	888 (49.7)
75–84	1049 (27.0)	626 (24.1)	646 (36.1)
85+	398 (10.2)	234 (9.0)	254 (14.2)
Sex, n (%)
Female	78 (2.0)	1420 (54.7)	1010 (56.5)
Male	3810 (98.0)	1175 (45.3)	777 (43.5)
≥1 benzodiazepine dispensed, n (%)	527 (13.6)	686 (26.4)	332 (18.6)
Age, n (%)
65–74	360 (68.3)	357 (52.0)	141 (42.5)
75–84	125 (23.6)	221 (32.3)	128 (38.7)
85+	43 (8.1)	108 (15.7)	62 (18.8)
Sex, n (%)
Female	14 (2.6)	439 (64.0)	221 (66.7)
Male	513 (97.4)	247 (36.0)	111 (33.3)